discussion / :@0.052618:0.143013:0.196466:0.143013:0.196466:0.122336:0.052618:0.122336:0.014581:0.005665:0.013113:0.013113:0.014581:0.013113:0.013113:0.005665:0.014581:0.014503:0.007396:0.007133:0.007291
consultation :@0.052618:0.164379:0.199304:0.164379:0.199304:0.143702:0.052618:0.143702:0.013113:0.014581:0.014503:0.013113:0.014581:0.005665:0.007396:0.014581:0.007291:0.005822:0.014503:0.014246:0.007291
Observation/ :@0.052618:0.185545:0.208111:0.185545:0.208111:0.164867:0.052618:0.164867:0.020509:0.014581:0.013113:0.014503:0.008812:0.012824:0.014581:0.007291:0.005822:0.014503:0.014581:0.007081:0.007291
Interview  :@0.052618:0.206710:0.171653:0.206710:0.171653:0.186032:0.052618:0.186032:0.007396:0.014581:0.007291:0.014319:0.008812:0.012824:0.005691:0.014791:0.018542:0.007497:0.007291
Practicum :@0.052618:0.228076:0.176214:0.228076:0.176214:0.207399:0.052618:0.207399:0.017388:0.008812:0.014581:0.013113:0.007291:0.005822:0.013113:0.014503:0.021683:0.007291
 :@0.052618:0.249241:0.059909:0.249241:0.059909:0.228564:0.052618:0.228564:0.007291
Employer Evaluation :@0.311170:0.143013:0.558269:0.143013:0.558269:0.122336:0.311170:0.122336:0.017388:0.021925:0.014581:0.005665:0.014581:0.012772:0.014581:0.008733:0.007448:0.017388:0.012824:0.014581:0.005665:0.014581:0.014503:0.007396:0.005691:0.014581:0.014923:0.007291
Weekly Reports :@0.311170:0.164379:0.502967:0.164379:0.502967:0.143702:0.311170:0.143702:0.025334:0.014241:0.014241:0.013375:0.005691:0.012824:0.007396:0.018804:0.014581:0.014503:0.014581:0.008497:0.007396:0.013043:0.007291
Final Narrative :@0.311170:0.185545:0.488325:0.185545:0.488325:0.164867:0.311170:0.164867:0.016024:0.005639:0.014581:0.014503:0.005691:0.007396:0.018804:0.014581:0.008733:0.008864:0.014581:0.007291:0.005822:0.012772:0.014581:0.007291
Report :@0.311170:0.206710:0.396853:0.206710:0.396853:0.186032:0.311170:0.186032:0.018804:0.014581:0.014503:0.014581:0.008733:0.007189:0.007291
Other requirements :@0.311170:0.228076:0.543523:0.228076:0.543523:0.207399:0.311170:0.207399:0.020509:0.007396:0.014581:0.014214:0.008812:0.007179:0.008812:0.014241:0.014791:0.014581:0.005665:0.008812:0.014241:0.021925:0.014581:0.014503:0.007396:0.012824:0.007291
(Waiver, Daily Time :@0.311170:0.249241:0.546310:0.249241:0.546310:0.228564:0.311170:0.228564:0.008261:0.025623:0.014241:0.005691:0.012824:0.014581:0.008733:0.007448:0.007396:0.018804:0.014581:0.005665:0.005691:0.012824:0.007396:0.016234:0.005691:0.021925:0.014241:0.007291
Record, Certificate of :@0.311170:0.270608:0.564012:0.270608:0.564012:0.249931:0.311170:0.249931:0.018804:0.014581:0.013113:0.014503:0.008812:0.014581:0.007081:0.007396:0.018804:0.014581:0.008733:0.007448:0.005429:0.007658:0.005691:0.013113:0.014241:0.007396:0.014581:0.007291:0.014319:0.007396:0.007291
Completion) :@0.311170:0.291773:0.459353:0.291773:0.459353:0.271096:0.311170:0.271096:0.018804:0.014581:0.021846:0.014581:0.005717:0.014581:0.007291:0.005822:0.014503:0.014581:0.008583:0.007291
 :@0.311170:0.312938:0.318460:0.312938:0.318460:0.292261:0.311170:0.292261:0.007291
Online Group :@0.052618:0.335162:0.215558:0.335162:0.215558:0.314484:0.052618:0.314484:0.020509:0.014581:0.005665:0.005691:0.014581:0.014503:0.007396:0.020246:0.008812:0.014581:0.014503:0.014581:0.007291
discussion:@0.052618:0.356327:0.174725:0.356327:0.174725:0.335649:0.052618:0.335649:0.014581:0.005665:0.013113:0.013113:0.014581:0.013113:0.013113:0.005665:0.014581:0.014581
 :@0.174625:0.356327:0.181915:0.356327:0.181915:0.335649:0.174625:0.335649:0.007291
Discussion on the :@0.052618:0.377693:0.266253:0.377693:0.266253:0.357016:0.052618:0.357016:0.018804:0.005691:0.013113:0.013113:0.014581:0.013113:0.013113:0.005665:0.014581:0.014503:0.007396:0.014581:0.014503:0.007396:0.007396:0.014581:0.014214:0.007291
introductory part of :@0.052618:0.398858:0.277845:0.398858:0.277845:0.378181:0.052618:0.378181:0.005691:0.014581:0.007291:0.008891:0.014581:0.014503:0.014581:0.013113:0.007291:0.014319:0.008812:0.012824:0.007396:0.014581:0.014503:0.008550:0.007396:0.007396:0.014241:0.007396:0.007291
EDP including its :@0.052618:0.420225:0.257362:0.420225:0.257362:0.399548:0.052618:0.399548:0.017388:0.018804:0.017388:0.007396:0.005691:0.014581:0.013113:0.005665:0.014581:0.014503:0.005691:0.014581:0.014765:0.007396:0.005691:0.007396:0.012824:0.007291
composition.’ :@0.052618:0.441390:0.212417:0.441390:0.212417:0.420713:0.052618:0.420713:0.013113:0.014581:0.021846:0.014581:0.014581:0.013113:0.005665:0.007396:0.005691:0.014581:0.014503:0.007396:0.005461:0.007291
Discussion of :@0.052618:0.462555:0.215480:0.462555:0.215480:0.441878:0.052618:0.441878:0.018804:0.005691:0.013113:0.013113:0.014581:0.013113:0.013113:0.005665:0.014581:0.014503:0.007396:0.014241:0.007658:0.007291
sample finished :@0.052618:0.483922:0.241447:0.483922:0.241447:0.463245:0.052618:0.463245:0.013113:0.014581:0.021846:0.014581:0.005717:0.014581:0.007084:0.007658:0.005691:0.014581:0.005665:0.013113:0.014581:0.014503:0.014241:0.007291
EDP. :@0.052618:0.505087:0.120912:0.505087:0.120912:0.484410:0.052618:0.484410:0.017389:0.018831:0.017389:0.007395:0.007291
Online Group :@0.052618:0.526454:0.215558:0.526454:0.215558:0.505776:0.052618:0.505776:0.020509:0.014581:0.005665:0.005691:0.014581:0.014503:0.007396:0.020246:0.008812:0.014581:0.014503:0.014581:0.007291
discussion on how :@0.052618:0.547619:0.273441:0.547619:0.273441:0.526941:0.052618:0.526941:0.014581:0.005665:0.013113:0.013113:0.014581:0.013113:0.013113:0.005665:0.014581:0.014481:0.007412:0.014538:0.014538:0.007411:0.014581:0.014503:0.018542:0.007291
to analyze/compute :@0.052618:0.568817:0.286447:0.568817:0.286447:0.548140:0.052618:0.548140:0.007396:0.014581:0.007291:0.014581:0.014581:0.014581:0.005639:0.012824:0.012824:0.014581:0.007291:0.013113:0.014581:0.021951:0.014581:0.014503:0.007396:0.014241:0.007291
the financial :@0.052618:0.590184:0.199561:0.590184:0.199561:0.569507:0.052618:0.569507:0.007396:0.014581:0.014503:0.007133:0.007658:0.005691:0.014581:0.014503:0.014581:0.013113:0.005665:0.014581:0.005665:0.007291
requirement or the :@0.052618:0.611349:0.273544:0.611349:0.273544:0.590672:0.052618:0.590672:0.008812:0.014241:0.014791:0.014581:0.005665:0.008812:0.014581:0.021846:0.014581:0.014267:0.007396:0.007396:0.014241:0.008812:0.007133:0.007396:0.014581:0.014503:0.007291
total project cost :@0.052618:0.632716:0.250229:0.632716:0.250229:0.612039:0.052618:0.612039:0.007396:0.014581:0.007291:0.014581:0.005744:0.007396:0.014241:0.008812:0.014581:0.005927:0.014241:0.013113:0.007133:0.007396:0.013113:0.014581:0.013113:0.007081:0.007291
and ROI:@0.052618:0.653881:0.149994:0.653881:0.149994:0.633204:0.052618:0.633204:0.014581:0.014503:0.014581:0.007291:0.018935:0.020194:0.007291
 :@0.149824:0.653881:0.157115:0.653881:0.157115:0.633204:0.149824:0.633204:0.007291
 :@0.052618:0.675248:0.059909:0.675248:0.059909:0.654570:0.052618:0.654570:0.007291
Submission of partial :@0.311170:0.335162:0.560944:0.335162:0.560944:0.314484:0.311170:0.314484:0.017388:0.014581:0.014503:0.021925:0.005691:0.013113:0.013113:0.005691:0.014581:0.014503:0.007396:0.014241:0.007396:0.007396:0.014581:0.014503:0.008550:0.007396:0.005691:0.014581:0.005665:0.007291
output per part :@0.311170:0.356327:0.488429:0.356327:0.488429:0.335649:0.311170:0.335649:0.014581:0.014503:0.007396:0.014581:0.014503:0.007133:0.007396:0.014581:0.014503:0.008550:0.007396:0.014581:0.014503:0.008550:0.007212:0.007291
EDP Title Defense  :@0.311170:0.377693:0.540881:0.377693:0.540881:0.357016:0.311170:0.357016:0.017388:0.018804:0.017388:0.007396:0.016234:0.005691:0.007396:0.005691:0.014581:0.007291:0.018935:0.014214:0.007396:0.014581:0.014503:0.013113:0.014581:0.007238:0.007291
EDP Proposal :@0.311170:0.398858:0.482608:0.398858:0.482608:0.378181:0.311170:0.378181:0.017388:0.018804:0.017388:0.007396:0.017388:0.008812:0.014581:0.014503:0.014581:0.013113:0.014503:0.005691:0.007291
Defense :@0.311170:0.420225:0.415667:0.420225:0.415667:0.399548:0.311170:0.399548:0.018804:0.014581:0.007632:0.014581:0.014214:0.013113:0.014280:0.007291
Examinations :@0.311170:0.441390:0.475316:0.441390:0.475316:0.420713:0.311170:0.420713:0.017388:0.012824:0.014581:0.021846:0.005822:0.014477:0.014581:0.007291:0.005822:0.014503:0.014581:0.013139:0.007291
Quizzes :@0.311170:0.462555:0.412816:0.462555:0.412816:0.441878:0.311170:0.441878:0.020509:0.014581:0.005665:0.012824:0.012824:0.014581:0.013371:0.007291
Seat works :@0.311170:0.483922:0.447665:0.483922:0.447665:0.463245:0.311170:0.463245:0.017388:0.014581:0.014503:0.007396:0.007396:0.018542:0.014581:0.008733:0.013113:0.012972:0.007291
Recitation :@0.311170:0.505087:0.434837:0.505087:0.434837:0.484410:0.311170:0.484410:0.018804:0.014581:0.013113:0.005665:0.007396:0.014581:0.007291:0.005822:0.014503:0.014621:0.007291
February 22, 2021 :@0.595163:0.335162:0.815966:0.335162:0.815966:0.314484:0.595163:0.314484:0.016024:0.014477:0.014581:0.008733:0.014581:0.014581:0.008733:0.012903:0.007396:0.014558:0.014581:0.007081:0.007396:0.014581:0.014503:0.014581:0.014220:0.007291
Online discussion :@0.052618:0.697219:0.264863:0.697219:0.264863:0.676542:0.052618:0.676542:0.020509:0.014581:0.005665:0.005691:0.014581:0.014503:0.007396:0.014581:0.005665:0.013113:0.013113:0.014581:0.013113:0.013113:0.005665:0.014581:0.014503:0.007291
on the concept of :@0.052618:0.718586:0.260510:0.718586:0.260510:0.697908:0.052618:0.697908:0.014581:0.014503:0.007396:0.007396:0.014581:0.014214:0.007396:0.013113:0.014581:0.014503:0.013113:0.014581:0.014214:0.007396:0.007396:0.014241:0.007396:0.007291
research and its :@0.052618:0.739751:0.246007:0.739751:0.246007:0.719073:0.052618:0.719073:0.008812:0.014581:0.013113:0.014503:0.014581:0.008733:0.013113:0.014319:0.007396:0.014581:0.014503:0.014581:0.007291:0.005481:0.007396:0.013113:0.007291
importance :@0.052618:0.760916:0.189042:0.760916:0.189042:0.740239:0.052618:0.740239:0.005691:0.021925:0.014581:0.014503:0.008812:0.007396:0.014581:0.014503:0.012824:0.014317:0.007291
Online Group :@0.052618:0.782282:0.215558:0.782282:0.215558:0.761605:0.052618:0.761605:0.020509:0.014581:0.005665:0.005691:0.014581:0.014503:0.007396:0.020246:0.008812:0.014581:0.014503:0.014581:0.007291
discussion / :@0.052618:0.803498:0.196466:0.803498:0.196466:0.782821:0.052618:0.782821:0.014581:0.005665:0.013113:0.013113:0.014581:0.013113:0.013113:0.005665:0.014581:0.014503:0.007396:0.007133:0.007291
reaction on the :@0.052618:0.824865:0.232894:0.824865:0.232894:0.804187:0.052618:0.804187:0.008812:0.014581:0.014503:0.013113:0.007396:0.005691:0.014581:0.014503:0.007396:0.014581:0.014214:0.007396:0.007396:0.014241:0.014581:0.007291
hypothesis of :@0.052618:0.846023:0.214037:0.846023:0.214037:0.825346:0.052618:0.825346:0.014581:0.012772:0.014581:0.014503:0.007396:0.014581:0.014503:0.013113:0.005691:0.013113:0.007396:0.014241:0.007658:0.007291
researches:@0.052618:0.867188:0.182016:0.867188:0.182016:0.846511:0.052618:0.846511:0.008812:0.014581:0.013113:0.014503:0.014581:0.008733:0.013113:0.014581:0.014267:0.013113
 :@0.181751:0.867188:0.189042:0.867188:0.189042:0.846511:0.181751:0.846511:0.007291
Proposed Research :@0.311170:0.697219:0.549667:0.697219:0.549667:0.676542:0.311170:0.676542:0.017388:0.008812:0.014581:0.014503:0.014581:0.013113:0.014503:0.014581:0.007291:0.018935:0.014503:0.013113:0.014581:0.014214:0.008812:0.013113:0.014581:0.007291
title/ topic :@0.311170:0.718586:0.428851:0.718586:0.428851:0.697908:0.311170:0.697908:0.007396:0.005691:0.007396:0.005691:0.014581:0.007291:0.007212:0.007396:0.014581:0.014503:0.005691:0.012962:0.007291
Evaluation of :@0.311170:0.739751:0.469783:0.739751:0.469783:0.719073:0.311170:0.719073:0.017388:0.012824:0.014581:0.005665:0.014581:0.014503:0.007396:0.005691:0.014581:0.014503:0.007396:0.014581:0.007632:0.007291
Introduction :@0.311170:0.760916:0.455077:0.760916:0.455077:0.740239:0.311170:0.740239:0.007396:0.014581:0.007081:0.008812:0.014581:0.014503:0.014581:0.013113:0.007291:0.005822:0.014503:0.014352:0.007291
formulation Review of :@0.311170:0.782282:0.569756:0.782282:0.569756:0.761605:0.311170:0.761605:0.007396:0.014581:0.008497:0.021925:0.014581:0.005665:0.014581:0.007291:0.005822:0.014503:0.014581:0.007291:0.018935:0.014503:0.012824:0.005691:0.014791:0.018542:0.007396:0.014241:0.007658:0.007291
related literature :@0.311170:0.803498:0.507243:0.803498:0.507243:0.782821:0.311170:0.782821:0.008812:0.014581:0.005665:0.014581:0.007291:0.014581:0.014581:0.007369:0.005691:0.005691:0.007396:0.014241:0.008812:0.014581:0.007291:0.014319:0.008812:0.014486:0.007291
Formulation of :@0.311170:0.824865:0.485414:0.824865:0.485414:0.804187:0.311170:0.804187:0.016024:0.014477:0.008812:0.021925:0.014581:0.005665:0.014581:0.007291:0.005822:0.014503:0.014241:0.007396:0.014241:0.007396:0.007291
hypothesis:@0.311170:0.846023:0.436004:0.846023:0.436004:0.825346:0.311170:0.825346:0.014581:0.012772:0.014581:0.014503:0.007396:0.014581:0.014503:0.013113:0.005691:0.013113
 :@0.436098:0.846023:0.443389:0.846023:0.443389:0.825346:0.436098:0.825346:0.007291
June 19, 2020 :@0.619109:0.697219:0.792021:0.697219:0.792021:0.676542:0.619109:0.676542:0.013113:0.014581:0.014503:0.014581:0.007291:0.014581:0.014581:0.007107:0.007396:0.014581:0.014503:0.014581:0.014220:0.007291